Home › NDC Lookup › RxCUI directory › RxCUI 2199304

0.1 ML glucagon 5 MG/ML Auto-Injector [Gvoke] — RxCUI 2199304

Name: 0.1 ML glucagon 5 MG/ML Auto-Injector [Gvoke] (RxCUI 2199304)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2199304 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2199304

Official name0.1 ML glucagon 5 MG/ML Auto-Injector [Gvoke]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as0.1 ML Gvoke 5 MG/ML Auto-Injector; Gvoke HypoPen 0.5 MG in 0.1 mL Auto-Injector; Gvoke HypoPen 0.5 MG per 0.1 mL Auto-Injector

FDA products mapped4

Package NDCs mapped7

Reported Medicaid activity (SDUD)67,274 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glucagon Nasal Powder: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Baqsimi is for severe low blood sugar emergencies — times when the person is unconscious, having a seizure, or so confused they can't safely eat or drink. Use it right away when yo...
When exactly should I use Baqsimi — and when should I call 911?
It's designed to be simple. Just take the device out of the tube, hold it under the person's nose, insert the tip into one nostril, and press the plunger all the way in until the g...
How do I actually give this? Is it hard to use?

📖 Read our full Glucagon Nasal Powder guide →

🕸️ Concept Web — How 0.1 ML glucagon 5 MG/ML Auto-Injector [Gvoke] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.1 ML glucagon 5 MG/ML Auto-Injector [Gvoke] RxCUI 2199304 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Glucagon 4832 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Gvoke 2199300 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Glucagon Auto-Injector 2199298 SCDF
- Glucagon Injectable Product 1165209 SCDG
- Glucagon Auto-Injector [Gvoke] 2199302 SBDF
- Gvoke Injectable Product 2199303 SBDG
- Auto-Injector 1649570 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.1 ML glucagon 5 MG/ML Auto-Injector 2199299 SCD
- Glucagon 5 MG/ML 2199297 SCDC
- Glucagon 5 MG/ML [Gvoke] 2199301 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.1 ML glucagon 5 MG/ML Auto-Injector SCD · 2199299
Glucagon 5 MG/ML SCDC · 2199297
Glucagon Auto-Injector SCDF · 2199298
Glucagon Injectable Product SCDG · 1165209

Brand-Name Concepts

Glucagon 5 MG/ML [Gvoke] SBDC · 2199301
Glucagon Auto-Injector [Gvoke] SBDF · 2199302
Gvoke Injectable Product SBDG · 2199303
Gvoke BN · 2199300

📦 FDA Products & Package NDCs

4 products · 7 package NDCs

7 package NDCs map to RxCUI 2199304 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
72065-0120-11	1 POUCH in 1 CARTON (72065-120-11) / 1 SYRINGE, PLASTIC in...	Gvoke HypoPen 0.5 mg Auto-Injector	Xeris Pharmaceuticals, Inc.	2019-09-10
72065-0120-12	2 POUCH in 1 CARTON (72065-120-12) / 1 SYRINGE, PLASTIC in...	Gvoke HypoPen 0.5 mg Auto-Injector	Xeris Pharmaceuticals, Inc.	2019-09-10
72065-0121-11	1 POUCH in 1 CARTON (72065-121-11) / 1 SYRINGE, PLASTIC in...	Gvoke HypoPen 1 mg Auto-Injector	Xeris Pharmaceuticals, Inc.	2019-09-10
72065-0121-12	2 POUCH in 1 CARTON (72065-121-12) / 1 SYRINGE, PLASTIC in...	Gvoke HypoPen 1 mg Auto-Injector	Xeris Pharmaceuticals, Inc.	2019-09-10
72065-0131-11	1 POUCH in 1 CARTON (72065-131-11) / 1 SYRINGE, PLASTIC in...	Gvoke PFS 1 mg Pre-filled Syringe	Xeris Pharmaceuticals, Inc.	2019-09-10
72065-0131-12	2 POUCH in 1 CARTON (72065-131-12) / 1 SYRINGE, PLASTIC in...	Gvoke PFS 1 mg Pre-filled Syringe	Xeris Pharmaceuticals, Inc.	2019-09-10
72065-0140-11	.2 mL in 1 CARTON (72065-140-11)	Gvoke Kit	Xeris Pharmaceuticals, Inc.	2021-10-11

Observed labelers: Xeris Pharmaceuticals, Inc. (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.